ArticleHeart failure reviews2025
Evaluating the role of mavacamten in symptomatic non-obstructive hypertrophic cardiomyopathy: the ODYSSEY-HCM trial.
Kaveh Hosseini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it